Transforming growth factor-β1 and its receptors in human lung cancer and mouse lung carcinogenesis

Experimental Lung Research

Volumn 26, Issue 8, 2000, Pages 685-707

  Kang, Y ^a   Prentice, M A ^a   Mariano, J M ^a   Davarya, S ^a   Ilona Linnoila, R ^a   Moody, T W ^a   Wakefield, L M ^a   Jakowlew, S B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carcinogenesis; Human; Lung cancer; Mouse; Receptor; TGF

Indexed keywords

RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRONCHIOLE; BRONCHUS MUCOSA; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOMA; ANIMALS; BLOTTING, WESTERN; BRONCHI; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG NEOPLASMS; MICE; MICE, INBRED A; MICE, INBRED C57BL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 0034525643     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140150216765     Document Type: Conference Paper

References (48)

1. Cancer statistics
2. Bronchioalveolar carcinoma
3. Respiratory tract and head and neck cancer
4. Analysis of long-term survivors with small-cell lung cancer
5. Primary lung tumors in mice: An experimentally manipulable model of human adenocarcinoma
6. Molecular comparison of human and mouse pulmonary adenocarcinomas
7. Transforming growth factor-beta
8. The TGF-β family and its composite receptors
9. Cloning of a receptor that forms a heteromeric complex with the TGF-β type II receptor
10. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
11. Concomitant loss of transforming growth factor-β receptors type I and type II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction
12. Inhibition of growth by transforming growth factor-β following fusion of two non-responsive human carcinoma cell lines
13. Genetic changes in the transforming β type II receptor gene in human gastric cells: Correlation with sensitivity to TGF-β
14. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
15. Expression and secretion of TGF-β isoforms and expression of TGF-β-receptors I, II and III in normal and neoplastic human breast
16. Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer
17. Down-regulation of TGF-β receptors in human colorectal cancer: Implications for cancer development
18. Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas
19. Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma
20. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
21. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
22. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
23. Expression of transforming growth factor β ligand and receptor messenger RNAs in lung cancer cell lines
24. Reduction of transforming growth factor-β receptor type II in mouse lung carcinogenesis
25. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
26. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
27. Western blotting
28. Enhanced expression of transforming growth factor-β and its type I and type II receptors in human glioblastoma tissues
29. Human pulmonary acinar aplasia: Reduction of transforming growth factor-β ligands and receptors
30. Transforming growth factor-beta receptors in human cancer cell lines: Analysis of transcript, protein and proliferation
31. Concurrent and distinct transcription and translation of transforming growth factor-β type I and type II receptors in rodent embryogenesis
32. Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells
33. Transfection of the type I TGF-β receptor restores TGF-β responsiveness in pancreatic cancer
34. Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinma MCF-7 cells
35. Transfection of the type II TGF-β receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype
36. Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small cell human lung carcinoma lines
37. Expression of TGF-β1, TGF-β2, and TGF-β3 in human small cell lung cancer cell lines
38. Growth suppression by transforming growth factor β1 of human small-cell human lung cancer cell lines is associated with expression of the type II receptor
39. Transforming growth factor β1 as a prognostic factor in pulmonary adenocarcinoma
40. Expression of PDGF, IGF-II, bFGF and TGF-β1 in pulmonary adenocarcinoma
41. Transforming growth factor β1, interleukin-8 and interleukin-1 in non-small-cell lung tumors
42. Transforming growth factor-β isoforms expressions in pulmonary adencarcinomas as prognostic markers
43. waf1/cip1 and transforming growth factor β1 protein expression correlate with survival in non-small cell lung cancer
44. Reduced transforming growth factor-β type II receptor (TGF-β RII) expression in adenocarcinoma of the lung
45. Roles of the transforming growth factor-β1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: Results of an immunohistochemical study
46. TGF-β signal transduction
47. Expression of transforming growth factor-β type II receptors in head and neck squamous cell carcinomas
48. Inheritance of pulmonary susceptibility in mice